Trinidad & Tobago STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago STEM News.

Press releases published on November 5, 2026

Nov. 5, 2026

AceUp Elevates Leadership Development Amid AI Transformation for NTT DATA Business Solutions with Ally 3.0

Indeterminate GlobeNewswire

Nov. 5, 2026

Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis

Indeterminate GlobeNewswire

Nov. 5, 2026

RemoFirst Launches a Global Infrastructure to Help Companies Manage and Pay Experts for AI Training

Indeterminate GlobeNewswire

Nov. 5, 2026

Nova Anchora Announces $23 Million Financing to Advance Topical Collagen VII Therapy for Dystrophic Epidermolysis Bullosa

Indeterminate GlobeNewswire

Nov. 5, 2026

Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense Markets

Indeterminate GlobeNewswire

Nov. 5, 2026

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product

Indeterminate GlobeNewswire

Nov. 5, 2026

Immutep Announces Upcoming Poster Presentations at CTOS 2026 and ESMO Immuno-Oncology & Advanced Therapies Congress 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Science 37 Named 2026 “BioTechnology Innovation of the Year” for its Direct-to-Patient Clinical Trial Delivery Model

Indeterminate GlobeNewswire

Nov. 5, 2026

Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

Nov. 5, 2026

Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

BriaCell Awarded 2026 “Immunotherapy Solution of the Year” By BioTech Breakthrough

Indeterminate GlobeNewswire

Nov. 5, 2026

Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

Verrica Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Altimmune to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Zscaler to Host First Quarter Fiscal Year 2027 Earnings Conference Call

Indeterminate GlobeNewswire

Nov. 5, 2026

Belite Bio to Host Webcast on November 12, 2026, to Discuss Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Wellchange Holdings Company Limited Announces 1-for-10 Reverse Stock Split Effective November 9, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

VeonGen Announces FDA Alignment on Pivotal Phase 3 Development and Clinical Progress of VG801 for Stargardt Disease

Indeterminate GlobeNewswire